These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
468 related items for PubMed ID: 26163269
41. Prognostic value of ABO blood group in patients with renal cell carcinoma: single-institution results from a large cohort. Lee C, You D, Sohn M, Jeong IG, Song C, Kwon T, Hong B, Hong JH, Ahn H, Kim CS. J Cancer Res Clin Oncol; 2015 Aug; 141(8):1441-7. PubMed ID: 25687379 [Abstract] [Full Text] [Related]
42. Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland. Weight CJ, Kim SP, Lohse CM, Cheville JC, Thompson RH, Boorjian SA, Leibovich BC. Eur Urol; 2011 Sep; 60(3):458-64. PubMed ID: 21514718 [Abstract] [Full Text] [Related]
47. Renal cell carcinoma of the native kidney: a frequent tumor after kidney transplantation with favorable prognosis in case of early diagnosis. Végsö G, Toronyi E, Hajdu M, Piros L, Görög D, Deák PA, Doros A, Péter A, Langer RM. Transplant Proc; 2011 May; 43(4):1261-3. PubMed ID: 21620106 [Abstract] [Full Text] [Related]
48. The Relationship Between Red Cell Distribution Width and Cancer-Specific Survival in Patients With Renal Cell Carcinoma Treated With Partial and Radical Nephrectomy. Życzkowski M, Rajwa P, Gabrys E, Jakubowska K, Jantos E, Paradysz A. Clin Genitourin Cancer; 2018 Jun; 16(3):e677-e683. PubMed ID: 29339043 [Abstract] [Full Text] [Related]
49. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Olweny EO, Park SK, Tan YK, Best SL, Trimmer C, Cadeddu JA. Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424 [Abstract] [Full Text] [Related]
50. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma. Komai Y, Saito K, Sakai K, Morimoto S. BJU Int; 2007 Jan; 99(1):77-80. PubMed ID: 16956357 [Abstract] [Full Text] [Related]
57. Low preoperative serum cholesterol level is associated with aggressive pathologic features and poor cancer-specific survival in patients with surgically treated renal cell carcinoma. Kang HW, Seo SP, Kim WT, Yun SJ, Lee SC, Kim WJ, Hwang EC, Kang SH, Hong SH, Chung J, Kwon TG, Kim HH, Kwak C, Byun SS, Kim YJ, KORCC (KOrean Renal Cell Carcinoma) group. Int J Clin Oncol; 2018 Feb; 23(1):142-150. PubMed ID: 28791497 [Abstract] [Full Text] [Related]
58. Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes. Psutka SP, Heidenreich M, Boorjian SA, Bailey GC, Cheville JC, Stewart-Merrill SB, Lohse CM, Atwell TD, Costello BA, Leibovich BC, Thompson RH. BJU Int; 2017 Jan; 119(1):116-127. PubMed ID: 27489013 [Abstract] [Full Text] [Related]
59. Perioperative epidural analgesia is not associated with increased survival from renal cell cancer, but overall survival may be improved: a retrospective chart review. Kovac E, Firoozbakhsh F, Zargar H, Fergany A, Elsharkawy H. Can J Anaesth; 2017 Jul; 64(7):754-762. PubMed ID: 28417354 [Abstract] [Full Text] [Related]